SCHEMBL8232016

SCHEMBL8232016

CC1=C(c2ccc(NC(=O)c3ccncc3C)cc2)CN(c2ncco2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.36
TYK2 P29597 1/20 0.35
RAF1 P04049 1/20 0.35
BRAF P15056 1/20 0.35
MCL1 Q07820 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
HTT P42858 2/20 0.34
NAMPT P43490 2/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL989393 0.91 STIM1 (0.42) MCL1L3MBTL1KDM4EALDH1A1NPC1
SCHEMBL8228702 0.83 PDGFRB (0.39) TYK2RAF1BRAFMCL1L3MBTL1
SCHEMBL989336 0.83 TRPV1 (0.44) CYP1A2TYK2L3MBTL1KDM4EALDH1A1
SCHEMBL8235476 0.83 ALDH1A1 (0.44) CYP1A2TYK2L3MBTL1KDM4EALDH1A1
SCHEMBL1780548 0.82 MAPT (0.39) TYK2KDM4EALDH1A1NPC1RAB9A
SCHEMBL8234885 0.82 NPC1 (0.43) CYP1A2KDM4EALDH1A1NPC1RAB9A
SCHEMBL987281 0.81 NPC1 (0.43) TYK2NPC1RAB9AHTTLMNA
SCHEMBL1780945 0.80 TRPV1 (0.47) TYK2L3MBTL1ALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL15654351 0.80 NPC1 (0.43) TYK2NPC1RAB9AHTTLMNA
SCHEMBL5019605 0.79 L3MBTL1 (0.35) TYK2MCL1L3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087443-A2 VINYL-PHENYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed